SUSAN GARBER: Open Payments
NPI 1427100023 · SUMMIT, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$673 in 28 payments from 17 companies in 2025. Trend: 2023 $1,394 · 2024 $1,392 · 2025 $673
Food & beverage: $673
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 4 | $136 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 2 | $121 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Merck Sharp & Dohme LLC | 3 | $50 |
| Novartis Pharmaceuticals Corporation | 3 | $44 |
| Baxter Healthcare | 1 | $37 |
| ENDOTRONIX, INC. | 1 | $31 |
| ABIOMED | 1 | $29 |
| Esperion Therapeutics, Inc. | 2 | $29 |
| AtriCure, Inc. | 1 | $24 |
Products named: Repatha, OFEV, VERQUVO, LEQVIO, Hillrom - Cardiac Ambulatory Monitor, FARXIGA, CORDELLA PULOMONARY ARTERY PRESSURE SENSOR, NEXLETOL.
Industry payments across NJ — which companies pay providers there.
